Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김진기 | - |
dc.date.accessioned | 2019-12-19T01:08:27Z | - |
dc.date.available | 2019-12-19T01:08:27Z | - |
dc.date.issued | 2019-08 | - |
dc.identifier.citation | MOLECULAR NEUROBIOLOGY, v. 56, No. 8, Page. 5539-5554 | en_US |
dc.identifier.issn | 0893-7648 | - |
dc.identifier.issn | 1559-1182 | - |
dc.identifier.uri | https://link.springer.com/article/10.1007%2Fs12035-019-1468-7 | - |
dc.identifier.uri | https://repository.hanyang.ac.kr/handle/20.500.11754/121325 | - |
dc.description.abstract | Neuropathic pain is a devastating chronic condition and effective treatments are still lacking. Carbon monoxide-releasing molecule-2 (CORM-2) as a carbon monoxide (CO) carrier, exerts potent anti-neuropathic pain effects; however, its poor water solubility and short half-life hinder its clinical utility. Therefore, the aim of this study was to investigate whether CORM-2-loaded solid lipid nanoparticles (CORM-2-SLNs) enhance the anti-allodynic and anti-hyperalgesic effects of CORM-2 in a rat chronic constriction injury (CCI) model. CORM-2-SLNs were prepared using a nanotemplate engineering technique with slight modifications. The physiochemical properties of CORM-2-SLNs were characterized and CO release from CORM-2-SLNs was assessed using a myoglobin assay. CO was slowly released from CORM-2-SLNs, was observed, and the half-life of CO release was 50 times longer than that of CORM-2. In vivo results demonstrate that intraperitoneal administration of CORM-2-SLNs (5 and 10mg/kg/day, ip) once daily for seven consecutive days significantly reduced the mechanical allodynia and mechanical hyperalgesia compared with CORM-2 (10mg/kg/day, ip). RT-PCR and Western blot analyses on days 7 and 14, revealed that treatment with CORM-2-SLNs resulted in greater reductions in the CCI-elevated levels of heme-oxygenase-2 (HO-2); inducible nitric oxide synthase (iNOS); neuronal NOS (nNOS); and inflammatory mediators (TNF-alpha, IBA-1, and GFAP) in the spinal cord and dorsal root ganglions compared with treatment with CORM-2. In contrast, HO-1 and IL-10 were significantly increased in the CORM-2-SLN-treated group compared with the group treated with CORM-2. These data indicate that CORM-2-SLNs are superior to CORM-2-S in alleviating mechanical allodynia and mechanical hyperalgesia. | en_US |
dc.description.sponsorship | This research was supported by the National Research Foundation (NRF) of Korea (NRF2017R1C1B1011397) and Korea Health Technology Research and Development Project, Ministry for Health and Welfare Affairs (HI16C1559, HI18C0183). This work was supported by the Basic Science Research Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (NRF-2017R1A2B4006458). | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | SPRINGER | en_US |
dc.subject | Neuropathic pain | en_US |
dc.subject | Nanoparticles | en_US |
dc.subject | Allodynia | en_US |
dc.subject | Hyperalgesia | en_US |
dc.subject | Carbon monoxide releasing molecule | en_US |
dc.subject | Carbon monoxide | en_US |
dc.title | Nanocarrier-mediated Delivery of CORM-2 Enhances Anti-allodynic and Anti-hyperalgesic Effects of CORM-2 | en_US |
dc.type | Article | en_US |
dc.relation.no | 8 | - |
dc.relation.volume | 56 | - |
dc.identifier.doi | 10.1007/s12035-019-1468-7 | - |
dc.relation.page | 5539-5554 | - |
dc.relation.journal | MOLECULAR NEUROBIOLOGY | - |
dc.contributor.googleauthor | Joshi, Hari Prasad | - |
dc.contributor.googleauthor | Kim, Sung Bum | - |
dc.contributor.googleauthor | Kim, Seungki | - |
dc.contributor.googleauthor | Kumar, Hemant | - |
dc.contributor.googleauthor | Jo, Min-Jae | - |
dc.contributor.googleauthor | Choi, Hyemin | - |
dc.contributor.googleauthor | Kim, Juri | - |
dc.contributor.googleauthor | Kyung, Jae Won | - |
dc.contributor.googleauthor | Sohn, Seil | - |
dc.contributor.googleauthor | Kim, Kyoung-Tae | - |
dc.contributor.googleauthor | Kim, Jin-Ki | - |
dc.contributor.googleauthor | Han, In-Bo | - |
dc.relation.code | 2019000135 | - |
dc.sector.campus | E | - |
dc.sector.daehak | COLLEGE OF PHARMACY[E] | - |
dc.sector.department | DEPARTMENT OF PHARMACY | - |
dc.identifier.pid | jinkikim | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.